Efficacy of budesonide in moderate to severe asthma

EJ O'Connell - Clinical therapeutics, 2002 - Elsevier
Background: The worldwide prevalence of asthma is increasing by∼ 50% per decade.
Budesonide is one of several inhaled corticosteroids available for the treatment of asthma …

Efficacy of budesonide in moderate to severe asthma.

EJ O'Connell - Clinical Therapeutics, 2002 - europepmc.org
BACKGROUND: The worldwide prevalence of asthma is increasing by approximately 50%
per decade. Budesonide is one of several inhaled corticosteroids available for the treatment …

[引用][C] Efficacy of budesonide in moderate to severe asthma

EJ O'Connell - Clinical Therapeutics, 2002 - cir.nii.ac.jp
Efficacy of budesonide in moderate to severe asthma | CiNii Research CiNii 国立情報学研究所
学術情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学 …

Efficacy of budesonide in moderate to severe asthma

EJ O'Connell - Clinical Therapeutics, 2002 - infona.pl
Background: The worldwide prevalence of asthma is increasing by∼ 50% per decade.
Budesonide is one of several inhaled corticosteroids available for the treatment of asthma …

[引用][C] Efficacy of Budesonide in moderate to severe asthma

EJ O'CONNELL - Clinical therapeutics, 2002 - pascal-francis.inist.fr
Efficacy of Budesonide in moderate to severe asthma CNRS Inist Pascal-Francis CNRS
Pascal and Francis Bibliographic Databases Simple search Advanced search Search by …

Efficacy of budesonide in moderate to severe asthma

EJ O'Connell - Clinical therapeutics, 2002 - pubmed.ncbi.nlm.nih.gov
Background The worldwide prevalence of asthma is increasing by approximately 50% per
decade. Budesonide is one of several inhaled corticosteroids available for the treatment of …

Efficacy of budesonide in moderate to severe asthma

EJ O'Connell - Clinical Therapeutics, 2002 - clinicaltherapeutics.com
Background: The worldwide prevalence of asthma is increasing by∼ 50% per decade.
Budesonide is one of several inhaled corticosteroids available for the treatment of asthma …

[引用][C] Efficacy of Budesonide in moderate to severe asthma

EJ O'CONNELL - Clinical therapeutics, 2002 - Elsevier